Jiangsu Nhwa Pharmaceutical Co., LTD (002262)

Overview

Jiangsu Nhwa Pharmaceutical Co., LTD is a prominent entity in the pharmaceutical industry, focusing on the research and development, production, marketing, and services pertaining to central nervous system drugs. The company has carved out a significant presence not only within China but also on an international scale. With a diverse portfolio aimed at addressing anesthesia, analgesia, mental disorders, neurological diseases, and includes both narcotic and psychiatric categories, Jiangsu Nhwa has established itself as a key player in healthcare. Since its inception in 1978, headquartered in Xuzhou, China, the company has dedicated itself to improving patient outcomes through their specialized products. Their distribution network is extensive, reaching customers through hospitals, private healthcare settings, online pharmacies, and chain pharmacies, ensuring their products are accessible to those in need.

Products and Services

Jiangsu Nhwa Pharmaceutical Co., LTD offers a comprehensive range of products and services tailored to meet the needs of patients suffering from various central nervous system disorders. The following are some of the key offerings:

• Anesthesia Products: The company develops drugs that are essential for conducting surgeries, including general anesthesia and local anesthetics, ensuring patients undergo procedures with minimal discomfort.
• Analgesia: These products are designed to manage pain effectively, ranging from mild to severe levels. They play a critical role in enhancing the quality of life for patients dealing with chronic pain conditions.
• Mental Disorders Treatments: Jiangsu Nhwa provides a range of pharmaceuticals aimed at treating various mental health conditions such as depression, anxiety, bipolar disorder, and schizophrenia, contributing to the overall well-being of patients.
• Neurological Disease Management: The company offers medications for a variety of neurological conditions, including epilepsy, Parkinson's disease, and multiple sclerosis, helping patients manage their symptoms and maintain neurological function.
• Narcotic and Psychiatry Medications: These include controlled substances used in the treatment of severe pain and psychiatric medications aimed at stabilizing mood and improving mental health.
• Active Pharmaceutical Ingredients (APIs): Jiangsu Nhwa also specializes in the production of high-quality APIs, which are the key components in the manufacture of pharmaceutical drugs. This not only supports their own product line but also caters to the needs of other pharmaceutical companies.